论文部分内容阅读
我院于1994—10～1996—04应用东菱精纳克栓酶（DF—521）治疗急性脑梗塞100例，取得满意疗效报告如下。1临床资料1.1及一般资料本组100例均经CT或MRI确诊的急性脑梗塞患者，发病时间均为＜24h，随机分为两组：冲击用量组（简称冲击组）50例，男31例，女19例。年龄40一78岁，平
Our hospital in 1994-10 ~ 1996-04 application of lingling sinanese thrombin enzyme (DF-521) in the treatment of acute cerebral infarction in 100 cases, obtained satisfactory curative effect report as follows. 1 Clinical data 1.1 and general information The group of 100 patients were confirmed by CT or MRI in patients with acute cerebral infarction, the onset time were <24h, were randomly divided into two groups: impact dose group (referred to as the impact group) 50 cases, 31 males , 19 females. Age 40 a 78 years old, flat